Exploring the Role of Apigenin in Neuroinflammation: Insights and Implications.

4′,5,7-trihydroxyflavone apigenin brain cancer flavonoids natural products neurodegenerative diseases neuroinflammation nutraceutical phytochemical

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 May 2024
Historique:
received: 25 03 2024
revised: 01 05 2024
accepted: 01 05 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 11 5 2024
Statut: epublish

Résumé

Neuroinflammation, a hallmark of various central nervous system disorders, is often associated with oxidative stress and neuronal or oligodendrocyte cell death. It is therefore very interesting to target neuroinflammation pharmacologically. One therapeutic option is the use of nutraceuticals, particularly apigenin. Apigenin is present in plants: vegetables (parsley, celery, onions), fruits (oranges), herbs (chamomile, thyme, oregano, basil), and some beverages (tea, beer, and wine). This review explores the potential of apigenin as an anti-inflammatory agent across diverse neurological conditions (multiple sclerosis, Parkinson's disease, Alzheimer's disease), cancer, cardiovascular diseases, cognitive and memory disorders, and toxicity related to trace metals and other chemicals. Drawing upon major studies, we summarize apigenin's multifaceted effects and underlying mechanisms in neuroinflammation. Our review underscores apigenin's therapeutic promise and calls for further investigation into its clinical applications.

Identifiants

pubmed: 38732259
pii: ijms25095041
doi: 10.3390/ijms25095041
pii:
doi:

Substances chimiques

Apigenin 7V515PI7F6
Anti-Inflammatory Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Karine Charrière (K)

Université de Franche-Comté, CHU Besançon, UMR 1322 LINC, INSERM CIC 1431, 25000 Besançon, France.

Vincent Schneider (V)

Centre des Sciences du Goût et de l'Alimentation, CNRS, INRAE, Institut Agro, Université de Bourgogne, 21000 Dijon, France.
Neurology and Clinical Neurophysiology Department, CHU F. Mitterrand, 21000 Dijon, France.

Manon Perrignon-Sommet (M)

Centre des Sciences du Goût et de l'Alimentation, CNRS, INRAE, Institut Agro, Université de Bourgogne, 21000 Dijon, France.

Gérard Lizard (G)

Bio-PeroxIL Laboratory, EA7270, University of Bourgogne, 21000 Dijon, France.

Alexandre Benani (A)

Centre des Sciences du Goût et de l'Alimentation, CNRS, INRAE, Institut Agro, Université de Bourgogne, 21000 Dijon, France.

Agnès Jacquin-Piques (A)

Centre des Sciences du Goût et de l'Alimentation, CNRS, INRAE, Institut Agro, Université de Bourgogne, 21000 Dijon, France.
Neurology and Clinical Neurophysiology Department, CHU F. Mitterrand, 21000 Dijon, France.
Memory Resource and Research Center (CMRR), CHU F. Mitterrand, 21000 Dijon, France.

Anne Vejux (A)

Centre des Sciences du Goût et de l'Alimentation, CNRS, INRAE, Institut Agro, Université de Bourgogne, 21000 Dijon, France.
Bio-PeroxIL Laboratory, EA7270, University of Bourgogne, 21000 Dijon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH